Rohit Aggarwal, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Alexion
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    ANI Pharmaceuticals
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Argenx
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Artasome
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    AstraZeneca
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Boehringer Ingelheim
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Boehringer Ingelheim
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Bristol Myers-Squibb
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bristol Myers-Squibb
    Date added:
    04/04/2024
    Date updated:
    08/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Cabaletta Bio
    Date added:
    04/04/2024
    Date updated:
    08/20/2024

Pages

Return to 2024 Inova Fairfax MGR (Enduring Material): Recent Updates in Myositis